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 ABSTRACT 
 
Given the difficulty of surgical resection of brain neoplasms located adjacent to vital structures 
of the brain as well as the challenges posed by the blood-brain-barrier for the efficacy of 
chemotherapeutic agents, whole brain radiation therapy (WBRT) and stereotactic radiosurgery 
(SRS) are often turned to for patients with brain metastases as well as primary brain neoplasms. 
Though radiation therapy may be successful in local control of these tumors, many patients 
experience treatment-related neurocognitive issues, later in life. In this review, we examine 
cognitive dysfunction in brain tumor patients following radiation therapy, with an emphasis on 
the pediatric population. Articles were found using NCBI’s PubMed and relevant search terms. 
We first review the hypotheses regarding the biological mechanisms underlying these neurologic 
manifestations such as neuroinflammation, extracellular matrix disruption, and inhibition of 
angiogenesis. Cognitive defects and related effects on health-related quality of life in brain tumor 
patients treated with radiotherapy are then discussed. We also address novel treatment strategies 
aimed at minimizing neurocognitive delays such as hippocampal-sparing radiotherapy planning, 
intensive chemotherapy regimens, and the growing field of proton therapy. Possible molecular 
therapeutic targets are discussed as well as preclinical studies examining human embryonic and 
neural stem cell transplantations. Finally, we examine the role of aerobic exercise, 
multidisciplinary rehabilitation, and other interventions that may help to curb the negative effects 
of radiotherapy on cognitive development and function. 
 
KEYWORDS:  brain tumor, WBRT, SRS, IMRT, cognitive decline, radiotherapy, pediatrics, 
memory impairment, hippocampus, neural stem cells  
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 Introduction 
 
Approximately 210,000 cases of primary and metastatic brain tumors are estimated to be 
diagnosed each year in the United States. Notably, primary brain tumors are the most common 
type of solid tumors in children (4,600 primary brain neoplasms are estimated to be diagnosed 
this year) and are the leading cause of cancer-related deaths in children under the age of 20. (1)  
 
Generally, surgery is the first method of treatment for brain tumor patients. However, tumors 
deeply-seated within the brain or located near critical structures that control important functions 
are difficult to remove due to possible iatrogenic neurologic damage. (2) Also, chemotherapy 
may be utilized for treatment, though the clinical applications of chemotherapy may be limited as 
a result of both significant side effects and insufficient delivery due to the blood-brain-barrier. 
(3)   
 
Thus, radiation therapy is often turned to for the treatment of both primary and metastatic brain 
neoplasms. (4,5) Roughly 200,000 brain tumor patients in the US are treated with some form of 
radiation each year. (6)  Specifically for brain cancers, stereotactic radiosurgery (SRS) and whole 
brain radiation therapy (WBRT) are often used. SRS delivers a high dose of radiation in one 
session, whereas WBRT administers ionizing radiation to the entire brain. However, the use of 
radiation therapy for the treatment of brain tumors is limited by the risk of radiation-induced 
damage and subsequent functional deficits. This review aims to summarize the neurocognitive 
effects following radiation therapy in patients with brain tumors with an emphasis on the 
pediatric population, novel methods of treatment aimed at minimizing cognitive dysfunction, as 
well as interventions that may be attempted should cognitive delays present. 
 
Methods 
 
We utilized NCBI’s PubMed to identify relevant articles using combinations of search terms 
such as: brain tumor, cognition, cognitive deficits, radiation therapy, proton therapy, stereotactic 
radiosurgery, whole brain radiation therapy, intervention, exercise, and pediatric. A total of 94 
papers were chosen for inclusion in this review. 
 
Hypotheses Explaining Radiation-Induced Cognitive Dysfunction 
There are many hypotheses that aim to explain the mechanisms underlying cognitive declines 
following radiation therapy. Most intuitive is the assumption that direct damage and subsequent 
death of parenchymal cells (oligodendrocytes, neurons, astrocytes, and microglia) contributes to 
cognitive decline. Damage to oligodendrocytes, which are responsible for myelination of the 
CNS, has been thought to play a role. Though studies examining rats undergoing fractionated 
WBRT did find a decrease in the number of oligodendrocytes, no change in the number of 
myelinated axons or the thickness of myelin sheaths were noted 12 months following treatment. 
(7,8)  Neurons in irradiated rodent brains are found to have altered expression of the immediate-
early gene activity-regulated cytoskeleton-associated protein, N-methyl-D-aspartate (NMDA) 
receptors, glutaminergic transmission, and hippocampal long-term potentiation, all of which are 
essential to synaptic plasticity and thus cognition. (9) The response of both astrocytes and 
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 microglia to radiation is thought to contribute to changes in the cellular microenvironment which 
will be discussed below. 
 
With regards to cognitive decline, radiation damage of the temporal lobe (specifically the 
hippocampus) likely plays a role. Both memory and learning are influenced by the proliferation 
of neural stem cells in the hippocampal granule cell layer, which allows for neuron renewal and 
synapse restructuring. In mature rats, the proliferative potential of this layer has been observed to 
be greatly reduced following radiation at doses lower than those typically required to injure 
dysplastic glial cells. (10)  However, in vivo studies have demonstrated that older rats 
experienced cognitive declines following WBRT without impaired hippocampal neurogenesis or 
demyelination seen in younger rats, suggesting that other mechanisms in non-hippocampal 
regions are likely to also contribute to neurocognitive issues. (9) 
 
As such, much of the literature has addressed disruption of the integrity of the blood-brain-
barrier (BBB) following radiotherapy as a possible explanation for impaired cognition. Increased 
inflammation following radiation therapy has been implicated. The up regulation of cytokines, 
which are thought to be expressed by microglia following radiation, and pro-inflammatory 
transcription factors in the brain are thought to contribute to endothelial cell dysfunction and 
consequent disruption of the BBB. (11,12)  The disruption of the extracellular matrix of the BBB 
may also be involved as WBRT has been previously documented as altering the expression of 
matrix metalloproteinases (MMP), leading to collagen IV degradation in both in vitro and in vivo 
studies. (13) Also, radiation inhibits physiologic angiogenesis in the brain, as evidenced by 
increased vascular permeability and impaired endothelial cell proliferation in irradiated tissues. 
(14) Studies have demonstrated that brain samples of rats exhibiting cognitive decline following 
fractionated WBRT had decreases in vessel density, cerebral blood flow, the number of 
endothelial cells, and angiogenic factors such as vascular endothelial growth factor (VEGF). 
(15,16)  
 
In addition to disruption of the BBB, the changes mentioned above may also play a role in stem 
cell lineage. Notably, a study by Monje et al. found that the changes outlined above were 
observed in the neural microenvironment of radiation-treated mice and resulted in hippocampal 
progenitor cells differentiating into glial rather than neural cells.17 In spite of these findings, there 
is still a poor understanding of the cellular or molecular mechanisms leading to cognitive 
dysfunction following radiotherapy. Elucidation of the hypotheses above has led to studies 
exploring them as potential therapeutic targets that will be discussed shortly. 
 
Cognitive Dysfunction and Related Effects on Quality of Life 
 
Retrospective studies estimate that neurologic handicaps and impaired cognition are observed in 
65% and 85%, respectively, of patients who were under 3 years of age when they underwent 
radiotherapy. (18) Many studies have aimed at particular cognitive defects to specific tumor type 
and location. For example, in children previously treated for pilocytic astrocytoma with normal 
intelligence prior to diagnosis, all children were noted to have deficits with sustained speech and 
speed of speech; radiotherapy in these patients further contributed to lower cognitive 
functioning. Notably, 60% of patients in this study had difficulty with academics 3 years after 
treatment. (19) Pediatric patients treated for medulloblastoma were not noted to have visual 
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 memory deficits as have been noted in other studies, though attention deficits were quite 
prominent and were correlated with impaired math and reading performance. (20) In comparing 
intellectual outcomes of children diagnosed with either ependymomas or medulloblastomas and 
subsequently treated with WBRT, only 10% of medulloblastoma patients had an IQ above 90 
after 10 years as compared to 60% of ependymoma patients and was hypothesized to be due to 
cerebral hemisphere radiation (given that this was the only significant difference between the 
two groups). (21) Notably, declines in both IQ as well as verbal comprehension seems to be 
dose-dependent, as children with posterior fossa tumors having received 35 Gy of radiation had 
lower average scores in both categories as compared to those receiving 0 and 25 Gy. (22)  
Similar studies have found that compared to age-matched controls, brain tumor patients treated 
with radiotherapy have significantly lower verbal IQ, processing speed, visual and verbal 
immediate memory, learning deficits, and selective attention. (23-26)  Interestingly, children with 
brain tumors have also been demonstrated to have significantly poorer working and verbal 
memory as well as attention deficits even prior to treatment, suggesting that interventions are 
necessary to mitigate the effects of both the disease process as well as radiotherapy on cognition. 
(27) 
 
Also of note is the strong correlation between cognitive dysfunction stemming from radiotherapy 
and a lower quality of life. (28,29)  Adults that had been previously diagnosed and treated for 
brain tumors in childhood have been found to have a 10%-23% lower likelihood of attaining a 
basic education, and this effect was even more marked for female survivors at a 45% lower 
probability compared to age-matched controls. A younger age of diagnosis was also significantly 
associated with a lower likelihood of completing basic education. (30,31)  Also, patients that had 
been previously diagnosed with CNS neoplasms and treated with WBRT had a roughly 10% 
lower likelihood of ever being married in their lifetime (this effect is even more pronounced at an 
estimated 29-38% lower likelihood for male CNS survivors older than 30 years of age). (32) 
Similar studies have found that CNS neoplasms survivors often have lower rates of educational 
attainment, employment, and marriage and consequently a significantly lower quality of life. 
(33) Survivors’ outlook on life is also impaired, as brain tumor survivors that underwent WBRT 
exhibit low present and expected future life satisfaction as well as higher rates of psychological 
distress as compared to survivors of other solid tumors.(34) The impaired psychosocial 
development of brain tumor survivors is also apparent as patients have been shown to be 50% 
more likely to experience depression or anxiety and 70% more likely to exhibit antisocial 
behaviors, with cranial irradiation being noted as a specific risk factor for both. (35) 
 
Alternative Radiotherapy Treatment Planning and the Promise of Proton Therapy 
 
Clinical studies have demonstrated that patients receiving higher doses of radiation (and 
subsequently larger volumes of the brain being treated) have worse prognosis regarding 
cognitive outcomes. (36,37)  Dose-dependent effects in pediatric brain tumor patients have been 
demonstrated with regard to motor skills/dexterity (hippocampus and temporal lobe), verbal 
learning (cerebrum), and visual perception (temporal lobe). Though declines relative to age-
matched controls were noted in a variety of other areas, no association was found between the 
neurologic structure radiated and the cognitive defect experienced for others tested (such as 
visuospatial working memory or vocabulary). (38) 
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 As such, many studies have examined alternative treatment strategies, such as utilizing SRS 
alone as opposed to WBRT and SRS to minimize the exposure of the brain to radiation. Patients 
with brain metastases treated with SRS alone experienced declines in Mini Mental Status 
Examination (MMSE) scores 9 months earlier than those assigned to WBRT and SRS, which 
suggests that control of tumor growth should be the primary concern for maintaining cognitive 
function. (39) However, other studies have found that patients treated with SRS alone had a 
lower incidence of experiencing decline in learning and memory function (24%) 4 months after 
treatment than those with WBRT and SRS (52%); consequently, the authors recommended initial 
SRS with close clinical monitoring before moving to use of WBRT. (40) Similarly, recent 
findings from a phase III randomized clinical trial of 213 patients with brain metastases (median 
follow-up: 7.3 months) found a significantly greater incidence of cognitive decline in patients 
treated with WBRT + SRS (91.7%) as compared to those receiving SRS alone (63.5%), with 
lower immediate recall, memory, verbal fluency and subsequently quality of life. (41)   
 
The advent of intensity-modulated radiotherapy (IMRT) has also allowed for treatment planning 
and contouring to avoid radiating hippocampal neural stem cells with WBRT.  Previous 
retrospective studies have demonstrated that WBRT with hippocampal sparing via IMRT 
reduced doses delivered on a per-fraction basis to the hippocampus by 87% (0.49 Gy) and 81% 
(0.73 Gy) via helical tomotherapy and linear accelerator-based treatments, respectively, with 
median doses of 5.5 Gy and 7.8 Gy delivered via the same methodologies. (42)  Similar studies 
adopting this approach for adult patients with brain metastases have reported significantly lower 
rates of memory loss 4 months post-treatment and with no treatment-related decline in quality of 
life.(43) A prospective phase II trial utilizing hippocampal sparing WBRT reported no 
significant declines in immediate verbal and nonverbal, executive functioning, or psychomotor 
speed following treatment, with delayed memory recall being the only neurocognitive function 
significantly affected. (44) 
 
Another approach is utilizing a lower dose of radiation with adjuvant chemotherapy. Early 
findings indicate that such an approach for lower to medium risk brain neoplasms can be curative 
and may be associated with declines in verbal, nonverbal, and full-scale IQ scores but less than 
those observed with higher doses of radiation alone.(45-48)  Other studies examining the role of 
postoperative chemotherapy to allow for a delay in radiotherapy for a variety of brain neoplasms 
had similar progression-free survival as compared to standard treatment plans including radiation 
with minimal observed cognitive dysfunction. (49,50) 
 
Most prominent among these trials are the “Head Start” trials, which attempt to use 
chemotherapy in place of radiotherapy for malignant brain neoplasms. Patients are placed on 
multiple cycles of chemotherapy for 5 months to reduce the size of the tumor and are then given 
a single large myeloablatic dose of chemotherapy followed by rescue with autologous 
hematopoietic stem cells. If no disease is seen on MRI following treatment, then radiotherapy is 
not used. Studies examining the effectiveness of this approach for supratentorial primitive 
neuroectodermal tumors (sPNETs), which typically have a poor prognosis, found a survival 
advantage as well as a significant decline in patients requiring radiation for local control. (51) 
Similarly, a majority of patients under the age of 3 years old with non-metastatic 
medulloblastoma treated under this regimen did not require radiation and consequently had both 
intelligence and quality of life scores within normal ranges, though there was a high toxicity-
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 related mortality rate (4/21). (52) Venkatramani et al. also reported the ability to defer radiation 
for supretentorial ependymomas, though for infratentorial ependymomas such an approach 
appears to be ineffective. (53) However, studies have previously demonstrated that 40% of 
cancer survivors of other sites experienced significant cognitive dysfunction after high dose 
chemotherapy followed by hematopoietic cell transplantation rescue 1 and 5 years post-
treatment; as such, monitoring patients on similar treatment protocols over a long time frame is 
needed. (54,55) 
 
Another novel treatment method that holds promise is proton-beam radiotherapy. Proton therapy 
is believed to result in greater sparing of healthy tissue and better outcomes due to narrower 
beams that may allow for a more-targeted delivery of radiation as well as a smaller penetration of 
tissue beyond the tumor. (56)  Given the new nature of this technology, relatively few clinical 
studies have been completed examining the theoretical advantages of proton therapy for brain 
neoplasms. Studies that have been done to estimate the clinical benefit of proton therapy based 
on simulated proton therapy for pediatric medulloblastoma cases found that the mean dose of 
radiation to the hippocampus could be limited to almost half that of IMRT and consequently 
lower the risk of cognitive issues later in life.(57) Notably, initial studies have demonstrated that 
the quality of life of 142 pediatric brain tumor patients 3 years after proton therapy improved to 
levels similar to healthy age-matched peers, though a comparison was not done comparing such 
patients to those treated with conventional radiotherapy and thus merits further study.(58) 
 
Results of Potential Therapeutic Targets and Stem Cell Therapies in Preclinical 
Trials 
 
Given the various radiation-induced mechanisms previously covered that are hypothesized to 
interfere with the integrity of the BBB and subsequently lead to cognitive dysfunction, a variety 
of molecular targets implicated in these mechanisms have been studied. For example, known 
anti-inflammatory agents such as NSAIDs, peroxisome proliferator-activated receptors (PPARδ) 
agonists, atorvastatin, and ramipril have been tested following WBRT in mice and rats to reduce 
microglial activation and subsequent inhibition of hippocampal neurogenesis. However, 
preclinical studies with the goal of minimizing neuroinflammation have yielded mixed results in 
preventing cognitive declines.(59-64) Though the possible role that MMPs may have in ECM 
degradation were previously discussed, presently no work has been done to examine whether this 
may provide benefit in pre-clinical irradiated brain studies. With regards to angiogenesis, 
systemic hypoxia following WBRT restored cerebrovascular density and reversed learning and 
memory impairments. As such, radio-protective drugs have been evaluated in preclinical trials 
and have been shown to be effective at protection of brain vasculature via preventing loss of 
endothelial cells and also lowering the proportion of rats brains demonstrating white matter 
necrosis.(15,65,66) However, studies utilizing any of these approaches have not been attempted 
in the clinic. 
 
Another field of study that have begun to draw interest are stem cell therapies, given prior 
studies in mouse models of Alzheimer’s disease that have demonstrated improved cognitive 
functioning following neural stem cell transplantation. A variety of mechanisms such as 
restoration of brain-derived neutrophic factor (BDNF) levels (involved in neuronal 
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 differentiation, neurogenesis, and synaptic plasticity necessary for long-term memory) as well as 
attenuation of inflammation via reduced cytokine expression has been proposed. (67-73) 
 
With regards to brain tumors and radiotherapy, it is believed that transplantation of stem cells 
can alleviate radiation-induced cognitive dysfunction by increasing the number of neurons via 
differentiation. Stem cells may also alter the neural microenvironment in the hippocampus to 
promote synaptic plasticity necessary for memory formation and information processing. 
Preclinical studies have found that athymic rats that had been both irradiated and had 
intrahippocampal transplantation of human neural stem cells (hNSCs) expressed activity-
regulated cytoskeleton-associated protein (Arc, an established marker for detecting active 
neurons) at similar levels to control levels. Rats undergoing transplantation were found to have 
consequently improved hippocampal spatial memory and a significantly lower decline in 
cognitive dysfunction. (74,75)  Intrahippocampal nHSCs transplantation has also been 
demonstrated to provide cognitive benefit lasting 8 months post-radiation (which was not 
observed following human embryonic stem cell transplantation) and may also attenuate 
radiation-induced neuroinflammation. (76,77)  Notably, transplantations were found to result in 
the greatest cognitive outcomes if given 4 weeks following radiation as opposed to 2 days or 1 
week after radiotherapy, with nearly 40% of surviving stem cells following a neuronal lineage in 
the CA1 and CA3 subfields of the hippocampus.(77) Also, human embryonic stem cell-derived 
oligodendrocytes in irradiated rats have been found to successfully migrate throughout major 
white matter tracts to participate in functional repair, which resulted in complete recovery of 
cognitive function to baseline levels. Motor deficits were also found to improve following 
transplantation of stem cell-derived oligodendrocytes into the cerebellum. (78) However, no 
significant clinical studies have been documented to our knowledge to date assessing the 
effectiveness of neural or embryonic stem cell intrahippocampal transplantations in either the 
pediatric or adult brain tumor populations. 
 
Aerobic Exercise, Multidisciplinary Rehabilitation, and Other Interventions 
 
In addition to the treatment options discussed earlier, many other interventions such as 
cardiovascular exercise may be helpful in improving cognitive functioning. Preclinical models 
have aimed at better elucidating whether exercise does attenuate radiation-induced cognitive 
dysfunction and the molecular mechanisms by which it may do so. Studies in mice have 
demonstrated that voluntary running starting 1 month following WBRT prevented marked 
declines in spacial memory, with possible mechanisms including partial neuron regeneration in 
the dentate gyrus and increased hippocampal expression of VEGF and IGF-1.(79)  Similar 
studies in irradiated rats have demonstrated that 3 weeks of forced running attenuated radiation-
induced declines in hippocampal neurons and expression of BDNF and was correlated with 
improved behavioral performance.(80) Declines in BDNF have been implicated in playing a 
large role in radiation-induced cognitive dysfunction, as other studies in rats subject to 30 Gy of 
WBRT have demonstrated significant declines in BDNF gene transcription via an epigenetic 
mechanism. Notably, a decrease in histone-deacetylase 1 (HDAC1) - dependent H3 acetylation 
was noted at BDNF gene promoters, which was reversed following administration of an HDAC 
inhibitor with consequent improved hippocampal neurogenesis.(81) As discussed earlier, BDNF 
plays a key role in memory formation via promotion of neuronal differentiation and 
neurogenesis, and attenuation of declines of BDNF in Alzheimer’s disease models and other 
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 neurocognitive disorders have been associated with improved learning and memory in preclinical 
models. 
 
Surprisingly, there have been a limited number of studies examining the effectiveness of exercise 
and other cognitive rehabilitations for both pediatric and adult brain tumor populations. Studies 
utilizing fMRIs for pediatric posterior fossa cancer survivors have demonstrated that declines in 
executive function, notably working memory, can be improved via cardiorespiratory exercise. 
(82)  However, levels of exercise among pediatric brain tumor survivors are reported to be 
greater than one standard deviation below age-matched peers, and as such interventions may be 
necessary to promote activity among such patients to realize potential cognitive benefits from 
exercise. (83-85) Furthermore, cognitive rehabilitation in glioma patients has been demonstrated 
to lead to improved verbal memory and attention with less mental fatigue 6 months after 
intervention as compared to control subjects.(86)  Four-week conventional rehabilitation 
programs (including physical and neuromuscular electrical stimulation as well as aerobic 
exercise) for brain tumor patients have noted similar success with significant rises in MMSE 
scores as well as visual attention, selective, and auditory attention.(87) Similarly, Gehring et al. 
reported significantly higher attention and visual memory scores among 140 adult survivors of 
low-grade and anaplastic astrocytoma patients 6-months following cognitive rehabilitation with 
less mental fatigue reported by patients undergoing rehabilitation. (88) Also, a cohort of 11 adult 
patients diagnosed with higher-grade gliomas (i.e. glioblastoma multiforme) with Karnofsky 
performance scores of 80% or higher participating in weekly neurocognitive rehabilitation 
sessions for 3 months exhibited higher mean attention, verbal, and memory scores, though only 
verbal scores exhibited significant increases from baseline.(89) A larger controlled clinical trial 
of over 100 adult glioma survivors participating in a multidisciplinary rehabilitation program 
found significant increases in self-care, locomotion, mobility, communication, and psychosocial 
scores at 3 month follow-up among the patients participating in the program compared to 
control, though only gains in cognition and communication were noted at 6 month follow-
up.(90) 
 
However, it is important to note that systemic reviews of multidisciplinary rehabilitation in brain 
tumor patients have found a “low-level” quality of evidence supporting rehabilitation for long-
term cognitive improvement.  Also, no studies thus far have clearly demonstrated significant 
improvements in health-related quality of life following such interventions. As such, studies 
examining the effect of exercise and cognitive rehabilitation on longer-term cognitive 
performance are warranted to better define the optimal setting, type, intensity, and duration of 
neurocognitive interventions, especially given the paucity of literature in the pediatric brain 
tumor population. (91) 
 
A variety of other alternative interventions have been attempted to prevent cognitive declines. 
Notably, Meyers et al. found that half of brain tumor patients who took the CNS stimulant 
methylphenidate before and during radiotherapy experienced cognitive function increases despite 
neurologic injury demonstrated on MRI. (92) However, more recent studies have found 
prophylactic methylphenidate does not result in a significant rise in MMSE scores or increases in 
quality of life. (93) Memantine, an NMDA antagonist commonly used in Alzheimer’s, and 
Ginkgo biloba (also used in Alzheimer’s to disease to improve cognitive deterioration) has been 
found to significantly prolong the time until onset of declining executive function and processing 
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 speed for patients with brain metastases treated with WBRT of up to 24 weeks with some 
improvements in quality of life. (94,95) 
 
Conclusion 
 
While great advances have been made in the treatment of cancer, cognitive disabilities may  
persist in patients (particularly children) with brain tumors for which radiotherapy remains a 
mainstay of treatment. Current research efforts aim to reduce neurotoxicity and associated 
cognitive dysfunction of treatment by alternative treatment planning such as larger doses of 
chemotherapy or avoiding vital structures such as the hippocampus during radiation planning via 
IMRT. It is a worthwhile endeavor to further elucidate the mechanisms by which radiation 
impairs cognitive abilities to allow for cellular and molecular pathways to be targeted in the 
future. Other innovative treatment modalities, namely proton therapy and intrahippocampal stem 
cell transplantations, may also have a large role to play in times to come given promising early 
findings with the objective of improving quality of life for cancer survivors. 
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